Clinical Risk Assessment in the Antiphospholipid Syndrome: Current Landscape and Emerging Biomarkers.
- Published in:
- Current Rheumatology Reports, 2017, v. 19, n. 7, p. 1, doi. 10.1007/s11926-017-0668-2
- By:
- Publication type:
- Article
Works matching IS 15233774 AND DT 2017 AND VI 19 AND IP 7
Results: 6
1
2
Framework for Advancing the Reporting of Patient Engagement in Rheumatology Research Projects.
- Published in:
- Current Rheumatology Reports, 2017, v. 19, n. 7, p. 1, doi. 10.1007/s11926-017-0666-4
- By:
- Publication type:
- Article
3
Antibodies Against Complement Components: Relevance for the Antiphospholipid Syndrome-Biomarkers of the Disease and Biopharmaceuticals.
- Published in:
- Current Rheumatology Reports, 2017, v. 19, n. 7, p. 1, doi. 10.1007/s11926-017-0669-1
- By:
- Publication type:
- Article
4
Autoinflammatory Diseases with Periodic Fevers.
- Published in:
- Current Rheumatology Reports, 2017, v. 19, n. 7, p. 1, doi. 10.1007/s11926-017-0670-8
- By:
- Publication type:
- Article
5
Rapidly Progressive Osteoarthritis: a Review of the Clinical and Radiologic Presentation.
- Published in:
- Current Rheumatology Reports, 2017, v. 19, n. 7, p. 1, doi. 10.1007/s11926-017-0665-5
- By:
- Publication type:
- Article
6
Rheumatoid Vasculitis: A Diminishing Yet Devastating Menace.
- Published in:
- Current Rheumatology Reports, 2017, v. 19, n. 7, p. 1, doi. 10.1007/s11926-017-0667-3
- By:
- Publication type:
- Article